Roche has an exquisite product pipeline full of innovation. This provides replacement power for outgoing patents and will nourish future growth in terms of sales and eps. Roche has it all to make a succesfull investment story.
- As existing patents expire, ongoing innovation is key to being successful in the pharma industry – Roche is doing extremely well in this respect,
- Roche mastered its steep patent cliff through high innovation power – Roche has once again confirmed that it is is the innovation leader in the industry,
- Roche’s GTM is faster than any other other entity – Roche has a pipeline that is filled with innovative product candidates which have all their potential to become blockbusters,
- A conservative view allow to understand that Roche sales growth will accelerate resulting in higher sales and EPS growth.